PhD MPHe BSc(Hons) PGCHET FHEA
Chair in Health Data Science
- About
-
- Email Address
- lesley.anderson@abdn.ac.uk
- Office Address
- School/Department
- School of Medicine, Medical Sciences and Nutrition
Biography
I joined the Aberdeen Centre for Health Data Science in March 2020. I trained at Queen's University Belfast (QUB) graduating with a PhD in cancer epidemiology in 2004 and an undergraduate degree (first class Honours) in Biomedical Science in 2001. I have a Masters in Population Health-based Evidence obtained by distance learning from the University of Manchester (distinction level) in 2006. I joined QUB as an academic in 2010 after completing two highly respected fellowships: an Academic Fellowship (funded by the UK Medical Research Council) and a Cancer Prevention Fellowship at the National Cancer Institute, National Institute of Health, Maryland, United States of America. I joined the Northern Ireland Cancer Registry (NICR) part-time in 2017 as Deputy Director overseeing the production of Official Statistics for Northern Ireland and developing the NICR Research Advisory Group.
I have over 19 years experience in research utilising healthcare data from the United Kingdom, Ireland, USA and Europe. I have established international partnerships within the USA, Europe, Australia, Africa and Asia to facilitate research in the fields of health data science and public health with a focus on cancer research. Global Health Research Partnerships with researchers in Angola, Mongolia and Vietnam are seeking to identify ways to improve public knowledge and reduce the burden of cancer. I am working to improve health care through Health Data Science research.
Qualifications
- PhD Public Health2004 - Queen's University BelfastTitle. The aetiology of Barrett's oesophagus and oesophageal adenocarcinoma: results from an all-Ireland case-control study.
- MPHe Population Health2006 - University of Manchester
- BSc (Hons) Biomedical Science2001 - Queen's University Belfast
- PGCHET Postgraduate Certificate in Higher Education Teaching2009 - Queen's University Belfast
Memberships and Affiliations
- Internal Memberships
-
- Senate Academicus, University of Aberdeen (Oct 2022-Sept 2026).
- Aberdeen Centre for Health Data Science Senior Leadership Team (Sept 2020-date)
- External Memberships
-
- External Programme and Module Examiner, Masters in Public Health, University of Manchester, 2019-2023.
- Cancer Research UK Prevention and Population Research Committee, Expert Review Panel (2022-date).
- Blood Cancer UK - Data themed Funding Committee (2022-date).
- Breast Cancer Now Tissue Bank Advisory Council (2021-date).
- National Cancer Research Institute Haematological Oncology Group member (2019-date)
Latest Publications
Pathways to MPN presentation and time-to-diagnosis: results from a cross-sectional study
BJGP OpenContributions to Journals: ArticlesAutoimmune Conditions and Gastric Cancer Risk in a Population-based Study in the United Kingdom
British Journal of Cancer, vol. 131, pp. 138-148Contributions to Journals: ArticlesPathways to MPN Presentation and Diagnosis: Results from a Cross-Sectional Study
BJGP OpenContributions to Journals: ArticlesA stakeholder analysis to prepare for real-world evaluation of integrating artificial intelligent algorithms into breast screening (PREP-AIR study): a qualitative study using the WHO guide
BMC Health Services Research, vol. 24, no. 1, 569Contributions to Journals: ArticlesService and clinical impacts of reader bias in breast cancer screening: a retrospective study
British Journal of Radiology, vol. 97, no. 1153, pp. 120-125Contributions to Journals: Articles
Prizes and Awards
- Positive Research Culture Award, Excellence Awards 2023, University of Aberdeen, 2023.
- Data Driven Innovation – iCAIRD for the implementation of our imaging research platforms (SHAIP and Pathology Living Lab). Holyrood Digital Health and Care Awards, 2023.
- iCAIRD won the Multiparty Collaboration Award at the Scottish Knowledge Exchange Awards in 2022.
- Innovative Collaboration Award: iCAIRD, Scotland’s Life Sciences Awards 2021.
- Outstanding Research Team – iCAIRD, Excellence Awards 2022, University of Aberdeen, 2022.
- Outstanding Research Project – Covid-19 Response & Recovery Award 2021, Excellence Awards 2021, University of Aberdeen, 20 21.
- STAR (STAff Recognition Scheme) for exceptional performance and contribution in your role. QUB, 2020.
- STAR (STAff Recognition Scheme) for exceptional performance and contribution in your role. QUB, 2019.
- Best Clinical Poster Prize, Haematology Association Ireland Annual Conference, October 2016.
- Presentation award. School of Medicine, Dentistry and Biomedical Sciences Postdoc Society Symposium, February 2010.
- Poster prize, Nursing and Allied Health Professional section, Cancer Recognised Research Group Retreat, September 2008.
- Dr J.D. Williamson Prize for best postgraduate medical research, Faculty of Medicine and Health Science, Queen’s University Belfast, 2007.
- Poster of Distinction. Digestive Disease Week, 2007.
- Highly commended for the BUPA Foundation Epidemiology Award, October 2005.
- Awarded best presentation at the Ulster Society of Gastroenterology meeting, October 2005.
- Travel scholarship for International Society of Gastrointestinal Oncology meeting, 2005.
- Digestive Disease Week Conference, May 2005. Platform presentation in the Distinguished Abstract Plenary Session. The abstract was noted as newsworthy.
- All Ireland Cancer Conference, 2003. Best poster prize.
- Awarded best presentation at the Ulster society of Gastroenterology meeting, March 2002
- Foundation Award, Queen’s University Belfast, 2001.
- Research
-
Research Overview
Health Data Research
Professor Anderson has over 19 years experience of using health data to research cancer and chronic disease epidemiology. Her research interests are aligned around the following research themes:
- Rare cancers
- Infection-related cancers
- Pre-cancerous conditions
- Chronic diseases
Research Areas
Applied Health Sciences
Biomedical Sciences
Research Specialisms
- Healthcare Science
- Biomedical Sciences
- Health Informatics
- Environmental and Public Health
- Oncology
Our research specialisms are based on the Higher Education Classification of Subjects (HECoS) which is HESA open data, published under the Creative Commons Attribution 4.0 International licence.
Current Research
Myeloproliferative neoplasms
Professor Anderson is leading the world's first nationwide case-control study of myeloproliferative neoplasms, the MOSAICC (MyelOproliferative neoplasmS: An In-depth Case-Control) study. The study will recruit patients from across the United Kingdom collecting information on potential risk factors (causes) and assessing the quality of life of these patients.
Infection-related cancers
Professor Anderson has undertaken research to investigate the knowledge and awareness of human papilloma virus (HPV) and how HPV may impact survival in patients with head and neck cancers.
Vitamin B12 Deficiency
Professor Anderson is interested in how vitamin B12 deficiency affects patients with pernicious anaemia and the ways in which treatment may be optimised. Working with the Pernicious Anaemia Society research is planned to evaluate the long term impacts of vitamin B12 deficiency.
Past Research
MOSAICC pilot study - largest study of myeloproliferative neoplasms to date. Study designed to determine best methodological approach for a UK-wide study which is ongoing looking at the aetiology and impact of a MPN diagnosis.
FINBAR study - large all-Ireland case-control study of oesophageal cancer and precancerous conditions. This study has led to many publications looking at the aetiology of these oesophageal conditions and is part of an international collaboration - the BEACON consortium.
EUROCARE - I have worked with the EUROCARE consortium to undertake a range of studies looking at variations in the survival of oesophgeal, gastric, small intestine and head and neck cancer and haematological malignancies.
RARECARE - I have worked with European colleagues to look at thyroid cancers and the burden and centralised treatment in Europe of rare tumours.
HPV and Head and Neck cancer - study identified that p16 is an insufficient marker for stage classification of oropharyngeal cancer. The data from this study is being combined with wider cohorts to evaluate this further and to look at restaging of oropharyngeal cancer.
COELIAC DISEASE - A study that I led looking at gluten sensitivity and coeliac disease and outcomes (cancer and all-cause mortality) led to the identification of adverse outcomes for those with gluten sensitivity but without a confirmed coeliac diagnosis.
MOSAICC Study
There is little information about what causes myeloproliferative neoplasms (MPNs). Patients often ask, “why do I have this disease?”, and for the majority there is no obvious reason. The MOSAICC study (MyelOproliferative neoplasmS: An In-depth Case-Control) is a UK-wide study that aims to identify what causes myeloproliferative neoplasms (MPNs). The MOSAICC study is open in 19 sites across the UK and in Cork Ireland.
Collaborations
Professor Anderson is a member of the BEACON consortium (https://esocan.org/beacon/).
Professor Anderson has research collaborations with researchers in the UK, Ireland, USA, across Europe, Australia, Angola, Vietnam and Mongolia.
Supervision
PhD
- 2nd supervisor: ‘Methods for the economic evaluation of artificial intelligence algorithms in breast cancer diagnosis.’ University of Aberdeen, 2023-2027. Funded: University of Aberdeen.
- 1st PhD supervisor: ‘Investigating the routes to diagnosis of Myeloproliferative Neoplasms using multidisciplinary approaches.’ University of Aberdeen, 2021-2025. Funded: University of Aberdeen.
- 1st PhD supervisor: ‘ARCHERY PROJECT: AI TO REVOLUTIONISE THE PATIENT CARE PATHWAY IN HIP AND KNEE ARTHROPLASTY’. University of Aberdeen, 2021-2024. Funded: Chief Scientist Office.
- 2nd PhD supervisor: ‘Investigating the significance of haematological malignancy precursors with a particular focus on multiple myeloma’, QUB 2019-2020. Funded: Dfe. Changed to 3rd supervisor when I changed job.
- 1st PhD supervisor: ‘Implementation of electronic cigarette policy in Kuwait.’ QUB 2016-2021. Funded: Kuwaiti government. Changed to 3rd supervisor when I changed job.
- 1st PhD supervisor: ‘Barriers to cervical cancer screening and diagnosis in Northern Ireland.’ QUB 2018-2021. Funded: Saudi/ Kuwaiti government. Changed to 3rd supervisor when I changed job.
- 1st PhD supervisor: ‘Assessing the impact of hydroxyurea treatment for children with sickle cell anaemia in Cabinda province, Angola.’ QUB 2016-2020. Funded: Angolan government.
- 1st PhD supervisor: ‘Assessing the impact of MGUS’, QUB 2015-date. Funded: DEL.
- 1st PhD supervisor: 'An exploratory case-control study of myeloproliferative neoplasms', QUB 2012-2015. Funded: MPN Voice.
- 1st PhD supervisor: 'Prior medical history, drug exposure and risk of multiple myeloma', QUB 2011-2013. Funded: DEL.
- 3rd PhD supervisor: ‘Investigating the association between aspirin & non-steroidal anti-inflammatory drugs and head and neck cancer & malignant melanoma’, QUB 2009-2011. Funded: DEL.
Masters
- 1st supervisor, MSc in Public Health: ‘Assessing knowledge and attitudes to artificial intelligence use in medical x-rays’, University of Aberdeen, 2022.
- 1st supervisor, MSc in Public Health: ‘Analysing the impact of social factors and distance to care on breast cancer outcomes in Scotland’, University of Aberdeen, 2021.
- 1st supervisor, MSc in Health Data Science: ‘Are Gluten-Free Foods Unhealthy?’, University of Aberdeen, 2021.
- 1st supervisor, MSc in Public Health: ‘Assessing the impact of COVID-19 on the quality of life of patients with a Myeloproliferative Neoplasm’, QUB 2020.
- 1st supervisor, MSc in Bioinformatics and computational genomics: ‘Natural Language Processing Tool for Breast Cancer Registration’, QUB 2020.
- 1st supervisor, MSc in Public Health: ‘Systematic review of arts-based approaches to increase awareness of breast cancer’, QUB 2019.
- 1st supervisor, MSc in Public Health: ‘Knowledge and attitudes of HPV in Angola’, QUB 2018.
- 1st supervisor, MSc in Public Health: ‘Attitudes and knowledge of parents to HPV vaccination – a quantitative investigation’, QUB 2016.
- 1st supervisor, MSc in Public Health: ‘Assessing the impact of MGUS’, QUB 2015.
- 1st supervisor, MSc in Public Health: ‘Anti-diabetic medications & risk of MGUS/myeloma’, QUB 2014.
- 1st supervisor, MSc in Public Health: ‘Investigating birth factors and Hodgkin lymphoma’, QUB 2010.
- 1st supervisor, MSc in Public Health.: ‘Investigating incidence trends of Human papillomavirus related and unrelated head and neck cancers’, QUB 2010.
- 1st supervisor, MPH: 'Determination of the predictors of Acute Human Immunodeficiency Virus type 1 and 2 for the targeted screening using p24 Enzyme Linked Immunosorbent Assay: a retrospective study from populations in Kenya, South Africa and Uganda' University of Liverpool, 2010.
Undergraduate
- 1st supervisor, Public Health ‘Attitudes and behaviours regarding tanning in Northern Ireland: A mixed-methods study of Queen’s University of Belfast students.’ UoA 2021-2022.
- 1st supervisor, Human Biology ‘Attitudes and behaviours regarding tanning in Northern Ireland: A mixed-methods study of Queen’s University of Belfast students.’ QUB 2017-2018.
- 1st supervisor, Human Biology ‘Coeliac Disease – Diagnosis, Trends, Cancer Risk and Mortality’ QUB 2017-2018.
- 2nd supervisor, Human Biology ‘Gluten Free’ Food for Thought.’ QUB 2018-2019.
- 1st supervisor, Human Biology ‘Occupational risk factors for myeloproliferative neoplasms.’ QUB 2017-2018.
- 1st supervisor, Human Biology ‘Incidence of Paediatric Cancer in Africa: a systematic review.’ QUB 2017-2018.
- 2nd supervisor, Human Biology ‘Knowledge, Attitudes & Practice of Paediatric Cancer in Africa: a systematic review’ QUB 2017-2018.
- 1st supervisor, Human Biology ‘Parental knowledge & attitudes to HPV vaccination.’ QUB 2016-2017.
- 1st supervisor, Human Biology ‘Oral dysplasia transformation rate’. QUB 2015/16.
- 1st supervisor, Human Biology ‘Incidence, prevalence and survival of MGUS’ QUB 2015-2016.
- 1st supervisor, Biomedical Science ‘Human Papilloma virus in head and neck cancers’, 2012-2013.
- 1st supervisor, Biomedical Science ‘Langerhans’ cells and immune response biomarkers in head and neck cancers’, 2012-2013.
- 1st supervisor, BSc Anatomy ‘Investigating psychological risk factors for oesophageal adenocarcinoma’, QUB 2010-2011.
- 1st supervisor, BSc Anatomy ‘Investigating survival differences between HPV-related and unrelated head and neck cancers’, QUB 2010-2011.
· Portfolio Tutor for undergraduate Medical students, 2010/11, 2011/12, 2015/16, 2016/17.
- Mentor for Biomedical Sciences, QUB, 2012-2014.
Funding and Grants
Current Research
- Anderson (PI), McShane, McMullin, McKnight. MPN Discovery - assessing gene-environment interaction. Blood Cancer UK. 2023-2026. £277,666.11.
- Anderson (PI), Toenail trace elements for assessing risk of myeloproliferative neoplasms. Friends of Anchor, 2023-2024. £11,193.
- Anderson (PI), Abutheraa N, Iversen L, Robertson C, Tarburn E. Investigating the incidence, prevalence and outcomes of myeloproliferative neoplasms to aid service planning and delivery in NHS Grampian. NHS Endowments, 2023-2024. £18,837.
- Anderson (PI), Lip (CI), Staff, De Vries. Grampian's Evaluation of Mia an Innovative National Breast Screening Initiative. Kheiron Medical Technologies Limited under NIHR Phase 4 AI Award. 2022-2023, £413,689 (£281,126 to UoA).
- Elsberger, Anderson (Co-I), Murchie. Scottish National Audit of Breast Cancer in Older Patients (S_NABCOP). NHSG Endownment Breast Cancer Research Fund 2022-2023, £13,422.
- Omar, Anderson (Co-I), MacLennan, MacLennan, Speirs & European Association of Urology Guidelines Office. Optimal treatment for patients with solid tumours in Europe through artificial intelligence.. European Commission, 2021-2026, €10,459,997.00 (£565,400 to UoA). Part of the 21.3 million Euro project. https://www.optima-oncology.eu/
- Farrow, Anderson (Co-I) & Ashcroft. ARCHERY PROJECT: AI TO REVOLUTIONISE THE PATIENT CARE PATHWAY IN HIP AND KNEE ARTHROPLASTY. Chief Scientist Office, Scotland, 2021-2024, £237,568.
- MOSAICC study https://www.qub.ac.uk/research-centres/CentreforPublicHealth/Research/CancerEpidemiology/MOSAICCStudy/
- Anderson (PI). MOSAICC (MyelOproliferative neoplasmS: An In-depth Case-Control) study in Aberdeen. Friends of Anchor, 2021-2023. £22,064.
- Anderson (PI), McShane, Mc Mullin, Duncombe, Fritschi, DeVocht, Mesa. MOSAICC study. MPN Voice. 2021-2023. £75,631.
- McShane, Anderson (Co-I), McMullin. MOSAICC study. Leukaemia and Lymphoma NI, £47,000. 2021-2022.
- McShane, Gavin, Anderson (Co-I). Investigating the impact of geographic inequalities and local service provision on multiple myeloma patient outcomes within the UK. Myeloma UK, 2021-2023. £100,000.
Prior Research
- Abderson (PI), Abutheraa N. Using Occupational Integrated Database Exposure Assessment (OccIDEAS) to assess occupational exposure risk for MyeloProliferative Neoplasms (MPN) patients and their control: A comparison study. University of Aberdeen Internal Funding to Pump-Prime Research and Research Networks. 2023. £9,931.75.
- Harrison, Blackwood, Anderson (Co-I). The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics https://icaird.com/. Extension bid (2022-2023). Innovate UK. £1,611,191. Total iCAIRD project grant £9,970,020 (UoA total: £394,477).
- Anderson (PI), D’Ambruoso, Camanda, Buco, Chocolate, Lohfeld. Evaluating opportunities and barriers to establishing an autonomous and functional sickle cell anaemia (SCA) unit in Cabinda, Angola. Scottish Funding Council, 2020-2021, £45,563.
- Murchie, Anderson (Co-I), Analysing NCDA data to support the adoption of Early Cancer Diagnostic Centres in Scotland. Chief Scientist Office, Scotland, 2021. £50,000.
- Black, Anderson (Co-I), Fluck, Hollick, Nath, Sawhney. MINIMISING IMPACT ON VULNERABLE PATIENTS: DATA DRIVEN DESIGN, MONITORING AND ADAPTATION OF COVID AND NON-COVID CLINICAL CARE PATHWAYS. Chief Scientist Office, Scotland. 2020. £61,452.
- McShane, Kunzmann, Anderson (Co-I), Lohfeld, Donnelly, Bayarmongol, Jigjidsuren, Enkhjargal, Tudev, Badamsuren, Jugder. Reducing cancer burden in Mongolia: Co-developing an Evidence-based Plan to Strengthen the Health Care System and Inform Policy. NIHR, £93,487.
- Gavin, Anderson (Co-I). Northern Ireland Colorectal cancer Audit, Public Health Agency Northern Ireland, £81,531.
- Gavin, Anderson (Co-I). Northern Ireland Cancer Registry, Public Health Agency Northern Ireland, £823,560.
- Gavin, Anderson (Co-I). Northern Ireland Cardiovascular Registry. Heart Research UK, 2019-2021. £149,991.
- Lohfeld, Anderson (Co-I), Santin, Donnelly, Franziska, Jenkins, Burgess, Nguyen, Murphy, Hang, Truong, Schroeder, Hang. Documenting how the arts and storytelling can save lives: The Viet Nam Breast Cancer project, MRC-AHRC. 2018-2020. £165,416.
- Anderson (PI), MOSAICC study. Leukaemia and Lymphoma NI, 2018-2021, £50,000.
- Teaching
-
Teaching Responsibilities
PhD Opportunities
Supervising students with an interest in Health Data Science and cancer research. Please contact lesley.anderson@abdn.ac.uk
- Publications
-
Page 1 of 4 Results 1 to 50 of 193
Pathways to MPN presentation and time-to-diagnosis: results from a cross-sectional study
BJGP OpenContributions to Journals: ArticlesAutoimmune Conditions and Gastric Cancer Risk in a Population-based Study in the United Kingdom
British Journal of Cancer, vol. 131, pp. 138-148Contributions to Journals: ArticlesPathways to MPN Presentation and Diagnosis: Results from a Cross-Sectional Study
BJGP OpenContributions to Journals: ArticlesA stakeholder analysis to prepare for real-world evaluation of integrating artificial intelligent algorithms into breast screening (PREP-AIR study): a qualitative study using the WHO guide
BMC Health Services Research, vol. 24, no. 1, 569Contributions to Journals: ArticlesService and clinical impacts of reader bias in breast cancer screening: a retrospective study
British Journal of Radiology, vol. 97, no. 1153, pp. 120-125Contributions to Journals: ArticlesRevisiting Cancer Diagnosis in Scotland: Further Insights from the Second Scottish National Cancer Diagnosis Audit
European Journal of Cancer Care, vol. 2024, 1117968Contributions to Journals: ArticlesThe aetiology and burden of myeloproliferative neoplasms in the United Kingdom: the MyelOproliferative neoplasmS: an In-depth case-control (MOSAICC) study protocol.
BMC Cancer, vol. 23, 1207Contributions to Journals: ArticlesThe JAK2V617F mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden
European Journal of Haematology, vol. 4, no. 4, pp. 1071-1080Contributions to Journals: ArticlesThe Impact of Rurality on Patient Experience and Diagnostic Pathway Intervals in Scotland’s Cancer Patients: Further Results from a National Cancer Diagnosis Audit Cancer Epidemiology
Cancer Epidemiology, vol. 86, 102414Contributions to Journals: ArticlesImpact of Different Mammography Systems on Artificial Intelligence Performance in Breast Cancer Screening
Radiology: Artificial Intelligence, vol. 5, no. 3, e220146Contributions to Journals: ArticlesAI in breast screening mammography: breast screening readers' perspectives
Insights into Imaging, vol. 13, no. 1, 186Contributions to Journals: ArticlesPrioritization of THose aWaiting hip and knee ArthroplastY(PATHWAY): protocol for development of a stakeholder led clinical prioritization tool
Bone & Joint Open, vol. 3, no. 10, pp. 753-758Contributions to Journals: ArticleseQTL set-based association analysis identifies novel susceptibility loci for Barrett's esophagus and esophageal adenocarcinoma
Cancer Epidemiology, Biomarkers and Prevention, vol. 31, no. 9, cebp.0096Contributions to Journals: ArticlesSupporting someone with cancer during the COVID-19 pandemic: A mixed methods analysis of cancer carer's health, Quality of Life and need for support
Health & Social Care in the Community, vol. 30, no. 5, pp. e3246-e3252Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1111/hsc.13768
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/19209/1/Santin_etal_HSC_Supporting_Someone_With_VoR.pdf
- [ONLINE] View publication in Scopus
- [ONLINE] View publication in Mendeley
Evaluation of Human Papillomavirus (HPV) Knowledge among Healthcare Professionals: A study of conference attendees in Angola
Global Public HealthContributions to Journals: ArticlesUsing Artificial Intelligence to Revolutionise the Patient Care Pathway in Hip and Knee Arthroplasty (ARCHERY): Protocol for the Development of a Clinical Prediction Model
JMIR Research Protocols, vol. 11, no. 5, e37092Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.2196/37092
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/18857/1/Farrow_et_al_Using_Artificial_JMIR_vor.pdf
- [ONLINE] View publication in Scopus
Spatial disparities in the reported incidence and survival of myeloproliferative neoplasms in Australia
Pathology, vol. 54, no. 3, pp. 328-335Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.pathol.2021.06.122
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/20358/2/Supplement_MPNs_spatial_epi.pdf
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/20358/3/MPN_spatial_epi_FINAL.pdf
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/20358/1/MPNs_estimates.xlsx
A National Network of Safe Havens: Scottish Perspective
Journal of Medical Internet Research, vol. 24, no. 3, pp. e31684Contributions to Journals: ArticlesMenopausal hormone therapy and risk of biliary tract cancers
Hepatology, vol. 75, no. 2, pp. 309-321Contributions to Journals: ArticlesNot all small HER2 positive breast cancers have the same clinical outcome in the North-East of Scotland
Cancer Treatment and Research Communications, vol. 31, no. 2022, 100549Contributions to Journals: ArticlesInterpretation and Reporting of Predictive or Diagnostic Machine Learning Research in Trauma & Orthopaedics
Bone and Joint Journal, vol. 103B, no. 12, pp. 1754-1758Contributions to Journals: ArticlesA systematic review and meta-analysis of cancer risk in myotonic dystrophy: consistent with a general increased risk of cancer
Neuromuscular Disorders, vol. 31, no. Supplement 1, S121Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1016/j.nmd.2021.07.261
The psychosocial impact of the COVID-19 pandemic on MGUS, smouldering and active myeloma patients: findings from an international survey
British Journal of Haematology, vol. 194, no. 2, pp. 294-297Contributions to Journals: LettersDoes risk of progression from Barrett’s esophagus to esophageal adenocarcinoma change based on the number of non-dysplastic endoscopies?
Digestive Diseases and Sciences, vol. 66, pp. 1965–1973Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1007/s10620-020-06483-0
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/16835/1/Barretts.pdf
- [ONLINE] View publication in Scopus
Patient's perspectives of living with a precancerous condition: monoclonal gammopathy of undetermined significance (MGUS)
European Journal of Oncology Nursing, vol. 51, 101901Contributions to Journals: ArticlesGermline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma
Carcinogenesis, vol. 42, no. 3, pp. 369-377Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1093/carcin/bgaa132
Impact of COVID19 Pandemic on an International MPN Patient Population: Survey Results from 1560 MPN Patients
62nd American Society of Hematology Annual Meeting and ExpositionContributions to Conferences: Abstracts- [ONLINE] Abstract
Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma
Gastroenterology, vol. 159, no. 6, pp. 2065-2076.E1Contributions to Journals: ArticlesAssociation Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus
Clinical Gastroenterology and Hepatology, vol. 18, no. 12, pp. 2701-2709.e3Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.cgh.2019.11.030
- [ONLINE] View publication in Scopus
Changes in the Demographic and Clinicopathological Characteristics of Thyroid Cancer: A Population-Based Investigation in Algeria, 1993-2013
Journal of Cancer Epidemiology, vol. 2020, 7812791Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1155/2020/7812791
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/15194/2/Article_Boukheris_et_al._IJC_Houda_Revised.docx
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/15194/1/Boukheris_et_al_JOCE_ChangesInTheDemogrphic_VoR.pdf
- [ONLINE] View publication in Scopus
Rare thyroid malignancies in Europe: data from the information network on rare cancers in Europe (RARECAREnet)
Oral Oncology, vol. 108, 104766Contributions to Journals: ArticlesAetiology of Myeloproliferative Neoplasms
Cancers, vol. 12, no. 7, pp. 1-11Contributions to Journals: Review articlesCancer incidence projections in Northern Ireland to 2040
Cancer Epidemiology, Biomarkers and Prevention, vol. 29, no. 7, pp. 1398-1405Contributions to Journals: ArticlesModifiable lifestyle and medical risk factors associated with myeloproliferative neoplasms
HemaSphere, vol. 4, no. 1, e327Contributions to Journals: ArticlesComparison of molecular assays for HPV testing in oropharyngeal squamous cell carcinomas: A population-based study in Northern Ireland
Cancer Epidemiology Biomarkers and Prevention, vol. 29, no. 1, pp. 31-38Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1158/1055-9965.EPI-19-0538
- [ONLINE] View publication in Scopus
- [ONLINE] Deposit in QUB repository
Improving identification of cognitive impairment in fragility fracture patients: impact of educational guidelines on current practice
Geriatric orthopaedic surgery & rehabilitation, vol. 11, pp. 1-7Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1177/2151459320935095
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/15118/2/Submitted_manuscript_Improving_screening_for_cognitive_impairment_manuscript.docx
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/15118/1/Kennedy_etal_GOSR_Improving_identification_VOR.pdf
- [ONLINE] View publication in Scopus
Diabetes in relation to Barrett’s esophagus and adenocarcinomas of the esophagus: a pooled study from the International Barrett’s and Esophageal Adenocarcinoma Consortium
Cancer, vol. 125, no. 23, pp. 4210-4223Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1002/cncr.32444
- [ONLINE] QUB Repository
Association between aspirin use and biliary tract cancer survival
JAMA Oncology, vol. 5, no. 12, pp. 1802-1804Contributions to Journals: LettersNo Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study
Clinical Gastroenterology and Hepatology, vol. 17, no. 11, pp. 2227-2235Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.cgh.2019.01.041
- [ONLINE] View publication in Scopus
Benign tumors in myotonic dystrophy type I target disease-related cancer sites
Annals of Clinical and Translational Neurology, vol. 6, no. 8, pp. 1510-1518Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1002/acn3.50856
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/14586/1/Alsagaff_etal_ACTN_Benign_Tumors_VOR.pdf
- [ONLINE] View publication in Scopus
Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink
Gut, vol. 68, no. 8, pp. 1458-1464Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1136/gutjnl-2018-317504
- [ONLINE] QUB repository
Predictors of an early death in patients diagnosed with colon cancer: A retrospective case-control study in the UK
BMJ Open, vol. 9, no. 6, e026057Contributions to Journals: ArticlesRecommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach
British Journal of Cancer, vol. 120, pp. 827-833Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/s41416-019-0414-9
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/14591/1/Craig_BJC_Recommendations_VOR.pdf
- [ONLINE] View publication in Scopus
Changing incidence of myeloproliferative neoplasms in Australia, 2003-2014
American Journal of Hematology, vol. 94, no. 4, pp. E107-E109Contributions to Journals: Letters- [ONLINE] DOI: https://doi.org/10.1002/ajh.25407
- [ONLINE] View publication in Scopus
Information on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk Factors
Gastroenterology, vol. 156, no. 1, pp. 43-45Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1053/j.gastro.2018.09.038
- [ONLINE] View publication in Scopus
- [ONLINE] Deposit in Queen's University Belfast repository
Communication strategies for rare cancers: A systematic review protocol
Systematic reviews , vol. 8, 102Contributions to Journals: Review articlesLow knowledge and awareness of monoclonal gammopathy of undetermined significance (MGUS) among general practitioners
BMC Family Practice, vol. 20, 61Contributions to Journals: ArticlesInteractions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus
Clinical Gastroenterology and Hepatology, vol. 16, no. 10, pp. 1598-1606.e4Contributions to Journals: ArticlesHelicobacter pylori Infection Is Associated With Reduced Risk of Barrett’s Esophagus: An Analysis of the Barrett’s and Esophageal Adenocarcinoma Consortium
American journal of gastroenterology, vol. 113, no. 8, pp. 1148-1155Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/s41395-018-0070-3
- [ONLINE] View publication in Scopus
Model for Identifying Individuals at Risk for Esophageal Adenocarcinoma
Clinical Gastroenterology and Hepatology, vol. 16, no. 8, pp. 1229-1236.e4Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.cgh.2018.03.014
- [ONLINE] View publication in Scopus